Douglas E. Murphy

921 total citations
16 papers, 355 citations indexed

About

Douglas E. Murphy is a scholar working on Organic Chemistry, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Douglas E. Murphy has authored 16 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Organic Chemistry, 10 papers in Molecular Biology and 3 papers in Infectious Diseases. Recurrent topics in Douglas E. Murphy's work include Quinazolinone synthesis and applications (5 papers), Phenothiazines and Benzothiazines Synthesis and Activities (4 papers) and Chemical Synthesis and Analysis (3 papers). Douglas E. Murphy is often cited by papers focused on Quinazolinone synthesis and applications (5 papers), Phenothiazines and Benzothiazines Synthesis and Activities (4 papers) and Chemical Synthesis and Analysis (3 papers). Douglas E. Murphy collaborates with scholars based in United States. Douglas E. Murphy's co-authors include Yuefen Zhou, Zhongxiang Sun, V. Gregor, Benjamin K. Ayida, Daniel Wall, Jamie M. Froelich, Stephen E. Webber, Geoffrey C. Winters, Sarah Fish and Peter S. Dragovich and has published in prestigious journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and Tetrahedron.

In The Last Decade

Douglas E. Murphy

16 papers receiving 325 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Douglas E. Murphy United States 10 223 162 51 34 34 16 355
Johan Gising Sweden 11 260 1.2× 182 1.1× 17 0.3× 83 2.4× 26 0.8× 33 419
Pavan Vaddady United States 7 92 0.4× 86 0.5× 17 0.3× 37 1.1× 22 0.6× 24 264
Joseph F. Leone United States 11 90 0.4× 149 0.9× 56 1.1× 101 3.0× 17 0.5× 16 324
Patrick DeRoy Canada 10 324 1.5× 102 0.6× 60 1.2× 92 2.7× 17 0.5× 12 461
Dmitry V. Kravchenko Russia 11 225 1.0× 112 0.7× 15 0.3× 33 1.0× 17 0.5× 39 388
Deping Chai United States 7 80 0.4× 64 0.4× 56 1.1× 35 1.0× 27 0.8× 8 162
Juliang Zhu United States 11 163 0.7× 117 0.7× 47 0.9× 80 2.4× 11 0.3× 16 382
Donna Skow United States 8 74 0.3× 139 0.9× 16 0.3× 35 1.0× 11 0.3× 10 269
Yung‐hyo Koh United States 9 235 1.1× 169 1.0× 17 0.3× 156 4.6× 12 0.4× 10 397
Yves Ribeill France 10 127 0.6× 260 1.6× 114 2.2× 61 1.8× 8 0.2× 22 476

Countries citing papers authored by Douglas E. Murphy

Since Specialization
Citations

This map shows the geographic impact of Douglas E. Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas E. Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas E. Murphy more than expected).

Fields of papers citing papers by Douglas E. Murphy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas E. Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas E. Murphy. The network helps show where Douglas E. Murphy may publish in the future.

Co-authorship network of co-authors of Douglas E. Murphy

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas E. Murphy. A scholar is included among the top collaborators of Douglas E. Murphy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas E. Murphy. Douglas E. Murphy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Murphy, Douglas E.. (2016). Last Futures: Nature, Technology and the End of Architecture. 5 indexed citations
2.
3.
Zhou, Yuefen, Chun Yuen Chow, Douglas E. Murphy, et al.. (2008). Antibacterial activity in serum of the 3,5-diamino-piperidine translation inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(11). 3369–3375. 9 indexed citations
4.
Zhou, Yuefen, Lian‐Sheng Li, Peter S. Dragovich, et al.. (2008). Novel HCV NS5B polymerase inhibitors derived from 4-(1′,1′-dioxo-1′,4′-dihydro-1′λ6-benzo[1′,2′,4′]thiadiazin-3′-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 2: Variation of the 2- and 6-pyridazinone substituents. Bioorganic & Medicinal Chemistry Letters. 18(4). 1419–1424. 18 indexed citations
5.
Zhou, Yuefen, Stephen E. Webber, Douglas E. Murphy, et al.. (2008). Novel HCV NS5B polymerase inhibitors derived from 4-(1′,1′-dioxo-1′,4′-dihydro-1′λ6-benzo[1′,2′,4′]thiadiazin-3′-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 1: Exploration of 7′-substitution of benzothiadiazine. Bioorganic & Medicinal Chemistry Letters. 18(4). 1413–1418. 26 indexed citations
6.
Dragovich, Peter S., Douglas E. Murphy, Sun Hee Kim, et al.. (2008). Efficient synthesis of (1R,2S) and (1S,2R)-2-aminocyclopentanecarboxylic acid ethyl ester derivatives in enantiomerically pure form. Tetrahedron Asymmetry. 19(24). 2796–2803. 6 indexed citations
7.
Dragovich, Peter S., David Ellis, Lian‐Sheng Li, et al.. (2008). Regiospecific Synthesis of Novel 6-Amino-5-hydroxypyridazin-3(2H)-ones. Synthesis. 2008(4). 610–616. 2 indexed citations
8.
Dragovich, Peter S., Douglas E. Murphy, Chinh Van Tran, & Frank Ruebsam. (2008). Efficient Large-Scale Synthesis of 2-Amino-5-methanesulfonylaminobenzenesulfonamide. Synthetic Communications. 38(12). 1909–1916. 3 indexed citations
9.
Murphy, Douglas E., Peter S. Dragovich, Benjamin K. Ayida, et al.. (2007). Efficient synthesis of 2,6-disubstituted-5-hydroxy-3-oxo-2,3-dihydro-pyridazine-4-carboxylic acid ethyl esters. Tetrahedron Letters. 49(5). 811–815. 20 indexed citations
10.
LI, L, S. E. Webber, Peter S. Dragovich, et al.. (2007). Potent HCV NS5B Polymerase Inhibitors Derived From 5-Hydroxy-3(2H)-Pyridazinones: Part 1Exploration of Pyridazinone 4-Substituent Variation. Antiviral Research. 74(3). A38–A38. 3 indexed citations
11.
Zhou, Yuefen, Jingjing Zhao, Peter S. Dragovich, et al.. (2007). Synthesis of New Pyridazinone Derivatives: 2,6-Disubstituted 5-Hydroxy-3(2H)-pyridazinone-4-carboxylic Acid Ethyl Esters. Synthesis. 2007(21). 3301–3308. 1 indexed citations
12.
Zhou, Yuefen, V. Gregor, Benjamin K. Ayida, et al.. (2006). Synthesis and SAR of 3,5-diamino-piperidine derivatives: Novel antibacterial translation inhibitors as aminoglycoside mimetics. Bioorganic & Medicinal Chemistry Letters. 17(5). 1206–1210. 119 indexed citations
13.
Dragovich, Peter S., Benjamin K. Ayida, Lian‐Sheng Li, et al.. (2006). Regiospecific synthesis of 1,5-disubstituted-1H-pyrazoles containing differentiated 3,4-dicarboxylic acid esters via Suzuki coupling of the corresponding 5-trifluoromethane sulfonates. Tetrahedron. 63(5). 1154–1166. 12 indexed citations
14.
Zhou, Yuefen, V. Gregor, Zhongxiang Sun, et al.. (2005). Structure-Guided Discovery of Novel Aminoglycoside Mimetics as Antibacterial Translation Inhibitors. Antimicrobial Agents and Chemotherapy. 49(12). 4942–4949. 41 indexed citations
15.
Zhou, Yuefen, Douglas E. Murphy, Zhongxiang Sun, & V. Gregor. (2004). Novel parallel synthesis of N-(4-oxo-2-substituted-4H-quinazolin-3-yl)-substituted sulfonamides. Tetrahedron Letters. 45(43). 8049–8051. 36 indexed citations
16.
González, Javier, V. Gregor, Atsuo Kuki, et al.. (2001). Identification of Alkylidene Hydrazides as Glucagon Receptor Antagonists. Journal of Medicinal Chemistry. 44(19). 3141–3149. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Johan Gising Breakdown of academic impact, for papers by Pavan Vaddady Breakdown of academic impact, for papers by Joseph F. Leone Breakdown of academic impact, for papers by Patrick DeRoy Breakdown of academic impact, for papers by Dmitry V. Kravchenko Breakdown of academic impact, for papers by Deping Chai Breakdown of academic impact, for papers by Juliang Zhu Breakdown of academic impact, for papers by Donna Skow Breakdown of academic impact, for papers by Yung‐hyo Koh Breakdown of academic impact, for papers by Yves Ribeill
Rankless by CCL
2026